Next Article in Journal / Special Issue
MicroRNA in Human Glioma
Previous Article in Journal
Peroxisome Proliferator-Activated Receptor and Vitamin D Receptor Signaling Pathways in Cancer Cells
Previous Article in Special Issue
Three-Times Daily Ultrafractionated Radiation Therapy, A Novel and Promising Regimen for Glioblastoma Patients
Cancers 2013, 5(4), 1271-1305; doi:10.3390/cancers5041271

Strategies in Gene Therapy for Glioblastoma

 and *
Received: 3 October 2013 / Accepted: 15 October 2013 / Published: 23 October 2013
(This article belongs to the Special Issue Glioblastoma)
View Full-Text   |   Download PDF [1466 KB, uploaded 23 October 2013]   |   Browse Figures
Abstract: Glioblastoma (GBM) is the most aggressive form of brain cancer, with a dismal prognosis and extremely low percentage of survivors. Novel therapies are in dire need to improve the clinical management of these tumors and extend patient survival. Genetic therapies for GBM have been postulated and attempted for the past twenty years, with variable degrees of success in pre-clinical models and clinical trials. Here we review the most common approaches to treat GBM by gene therapy, including strategies to deliver tumor-suppressor genes, suicide genes, immunomodulatory cytokines to improve immune response, and conditionally-replicating oncolytic viruses. The review focuses on the strategies used for gene delivery, including the most common and widely used vehicles (i.e., replicating and non-replicating viruses) as well as novel therapeutic approaches such as stem cell-mediated therapy and nanotechnologies used for gene delivery. We present an overview of these strategies, their targets, different advantages, and challenges for success. Finally, we discuss the potential of gene therapy-based strategies to effectively attack such a complex genetic target as GBM, alone or in combination with conventional therapy.
Keywords: gene therapy; oncolytic virus; stem cells; nanotechnology; gene transfer; glioma invasion; suicide gene; immunomodulation gene therapy; oncolytic virus; stem cells; nanotechnology; gene transfer; glioma invasion; suicide gene; immunomodulation
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |

MDPI and ACS Style

Kwiatkowska, A.; Nandhu, M.S.; Behera, P.; Chiocca, E.A.; Viapiano, M.S. Strategies in Gene Therapy for Glioblastoma. Cancers 2013, 5, 1271-1305.

AMA Style

Kwiatkowska A, Nandhu MS, Behera P, Chiocca EA, Viapiano MS. Strategies in Gene Therapy for Glioblastoma. Cancers. 2013; 5(4):1271-1305.

Chicago/Turabian Style

Kwiatkowska, Aneta; Nandhu, Mohan S.; Behera, Prajna; Chiocca, E. A.; Viapiano, Mariano S. 2013. "Strategies in Gene Therapy for Glioblastoma." Cancers 5, no. 4: 1271-1305.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert